首页> 外文OA文献 >Vital capacity and COPD: the Swedish CArdioPulmonary bioImage Study (SCAPIS)
【2h】

Vital capacity and COPD: the Swedish CArdioPulmonary bioImage Study (SCAPIS)

机译:肺活量和COPD:瑞典CArdio肺生物图像研究(SCAPIS)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: Spirometric diagnosis of chronic obstructive pulmonary disease (COPD) is based on the ratio of forced expiratory volume in 1 second (FEV1)/vital capacity (VC), either as a fixed value <0.7 or below the lower limit of normal (LLN). Forced vital capacity (FVC) is a proxy for VC. The first aim was to compare the use of FVC and VC, assessed as the highest value of FVC or slow vital capacity (SVC), when assessing the FEV1/VC ratio in a general population setting. The second aim was to evaluate the characteristics of subjects with COPD who obtained a higher SVC than FVC. Methods: Subjects (n=1,050) aged 50-64 years were investigated with FEV1, FVC, and SVC after bronchodilation. Global Initiative for Chronic Obstructive Lung Disease (GOLD) COPDFVC was defined as FEV1/FVC <0.7, GOLDCOPD(VC) as FEV1/VC <0.7 using the maximum value of FVC or SVC, LLNCOPDFVC as FEV1/FVC below the LLN, and LLNCOPDVC as FEV1/VC below the LLN using the maximum value of FVC or SVC. Results: Prevalence of GOLDCOPD(FVC) was 10.0% (95% confidence interval [CI] 8.2-12.0) and the prevalence of LLNCOPDFVC was 9.5% (95% CI 7.8-11.4). When estimates were based on VC, the prevalence became higher; 16.4% (95% CI 14.3-18.9) and 15.6% (95% CI 13.5-17.9) for GOLDCOPD(VC) and LLNCOPDVC, respectively. The group of additional subjects classified as having COPD based on VC, had lower FEV1, more wheeze and higher residual volume compared to subjects without any COPD. Conclusion: The prevalence of COPD was significantly higher when the ratio FEV1/VC was calculated using the highest value of SVC or FVC compared with using FVC only. Subjects classified as having COPD when using the VC concept were more obstructive and with indications of air trapping. Hence, the use of only FVC when assessing airflow limitation may result in a considerable under diagnosis of subjects with mild COPD.
机译:背景:慢性阻塞性肺疾病(COPD)的肺功能测定诊断基于1秒时的呼气量(FEV1)/肺活量(VC)的比率,固定值<0.7或低于正常值的下限( LLN)。强制肺活量(FVC)是VC的代理。第一个目的是比较在一般人群中评估FEV1 / VC比率时,将FVC和VC的使用评估为FVC的最高值或慢肺活量(SVC)。第二个目的是评估获得SVC高于FVC的COPD受试者的特征。方法:对年龄在50-64岁的受试者(n = 1,050)进行支气管扩张后,对其进行FEV1,FVC和SVC的调查。慢性阻塞性肺疾病全球倡议(GOLD)将COPDFVC定义为FEV1 / FVC <0.7,使用FVC或SVC的最大值将GOLDCOPD(VC)定义为FEV1 / VC <0.7,将LLNCOPDFVC定义为低于LLN的FEV1 / FVC,使用FVC或SVC的最大值将LLNCOPDVC设置为LLN以下的FEV1 / VC。结果:GOLDCOPD(FVC)的患病率为10.0%(95%置信区间[CI] 8.2-12.0),LLNCOPDFVC的患病率为9.5%(95%CI 7.8-11.4)。当基于VC进行估算时,患病率会更高;对于GOLDCOPD(VC)和LLNCOPDVC,分别为16.4%(95%CI 14.3-18.9)和15.6%(95%CI 13.5-17.9)。与没有任何COPD的受试者相比,根据VC分类为具有COPD的其他受试者组具有较低的FEV1,更多的喘息和较高的残留量。结论:与仅使用FVC相比,使用SVC或FVC的最大值计算FEV1 / VC比率时,COPD的患病率显着更高。使用VC概念时被归类为COPD的受试者更具阻塞性,并且有空气滞留的迹象。因此,在评估气流受限时仅使用FVC可能会导致轻度COPD患者的诊断不足。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号